Objective
Patients and society expect that technical and scientific advances can provide novel improved answers to address unmet medical needs. Parkinson's disease (PD) is the 2nd most prevalent neurodegenerative disorder in the world, with profound economic and social impacts. The absence of preventive therapies to tackle PD, requires the development of new therapeutic strategies. For Pharma companies, aiming to develop molecules for Parkinson Disease (PD) and other neurologic disorders, Fastprinciple is developing a new drug candidate, to be used as a future therapy to slow-down PD progression. Unlike alternative solutions (such as the ones commercialized by Bial, Acadia Pharmaceuticals, Abbvie, Lilly, and others), which target the symptoms, we expect to slow down the disease progression, increasing current therapies’ effectiveness overtime. PD affects more than 10 million people globally and has an enormous social and economic burden. Current treatments manage the symptoms of the disease but do not offer the patients the possibility of a cure. Unfortunately, as the disease progress to higher debilitating stage, the patient stops responding to the current symptomatic therapies, ending without therapeutic options. We have identified a molecule that with the company’s patented reformulation technology will improve the drug efficacy and slowdown the disease progression of the disease. The current proposal aims to establish FastPrinciple’s Strategic monetization plan, by securing IP strategy and to ameliorate our business and exploitation plan.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
- medical and health sciences basic medicine neurology parkinson
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.3.2 - European innovation ecosystems
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-CSA - HORIZON Coordination and Support Actions
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-EIE-2022-SCALEUP-02
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
6200-284 Covilha
Portugal
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.